Opendata, web and dolomites

TOBeATPAIN SIGNED

Targeting neuroinflammation to combat pathological pain in neurodegenerative diseases and chronic pain syndromes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TOBeATPAIN project word cloud

Explore the words cloud of the TOBeATPAIN project. It provides you a very rough idea of what is the project "TOBeATPAIN" about.

integrate    releasing    interact    pain    interdisciplinary    network    secondments    specialized    eleven    multidisciplinary    neuropathies    skills    young    supervision    industrial    innovation    quality    central    sme    cns    aligned    oriented    macrophages    training    academic    treatment    valuable    perception    neurodegenerative    acquisition    underlying    union    scientific    prevalence    mechanisms    employability    impair    molecules    causes    knowledges    communication    beneficiaries    scientists    astrocytes    countries    career    gain    minded    delivers    glia    neuroinflammation    nervous    triangle    sectorial    inter    platform    pharmaceutical    expertise    peripheral    inflammatory    cells    innovative    entrepreneurially    itn    performance    encompassing    charity    pns    damage    complementary    signalling    whereby    creation    altered    transferable    sectors    profit    tobeatpain    origin    combines    smes    musculoskeletal    mechanism    decreases    business    esrs    suggest    life    perceive    companies    neurones    local    technologies    forging    pathological    modulate    education    transnational    microglia    diseases    neuronal      

Project "TOBeATPAIN" data sheet

The following table provides information about the project.

Coordinator
KING'S COLLEGE LONDON 

Organization address
address: STRAND
city: LONDON
postcode: WC2R 2LS
website: www.kcl.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 2˙870˙359 €
 EC max contribution 2˙870˙359 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2022-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KING'S COLLEGE LONDON UK (LONDON) coordinator 546˙575.00
2    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 527˙318.00
3    Universitätsklinikum Jena DE (Jena) participant 498˙432.00
4    Eli Lilly and Company Limited UK (Basingstoke) participant 273˙287.00
5    KANCERA AB SE (SOLNA) participant 263˙659.00
6    BIONORICA RESEARCH GMBH AT (INNSBRUCK) participant 255˙934.00
7    MEDIZINISCHE UNIVERSITAT INNSBRUCK AT (INNSBRUCK) participant 255˙934.00
8    UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT DE (WURZBURG) participant 249˙216.00

Map

 Project objective

Damage to the central (CNS) and peripheral (PNS) nervous systems causes altered perception of pain (pathological pain) which is a common feature of diseases that have high prevalence in the European Union. Both increases and decreases in the ability to perceive pain impair both performance at work and quality of life. Pathological pain in neurodegenerative diseases, musculoskeletal diseases and peripheral neuropathies is associated with neuroinflammation, the inflammatory process whereby non-neuronal (inflammatory and glia) cells interact with neurones by releasing molecules that modulate pain signalling. TOBeATPAIN suggest that neuroinflammation represents an underlying mechanism of pathological pain states encompassing those with a PNS or CNS origin. The focus of this ITN will be on the mechanisms by which non-neuronal cells impact on neuronal activity in order to identify innovative non-neuronal targets for the treatment of pathological pain in peripheral macrophages or CNS microglia/astrocytes. TOBeATPAIN delivers high-level scientific and innovation-oriented complementary training, forging career pathways to increase inter-sectorial and transnational employability of young entrepreneurially-minded scientists in the academic and industrial sectors. It combines the expertise of 5 leading academic institutions, 2 pharmaceutical companies and 1 SME as Beneficiaries, together with 2 SMEs and 1 non-profit research charity as Partner Organisations, from 4 European countries. Fully aligned with the ‘Knowledge Triangle’ (business, research, higher education) platform, eleven ESRs will gain valuable knowledge and multidisciplinary skills through interdisciplinary research projects that integrate state-of-the-art technologies, supervision by and secondments to industrial Network organisations, Network-wide and local training activities, and specialized transferable skills focused in the acquisition of the ‘3-Knowledges’ (K-creation, K-exploitation, K-communication).

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TOBEATPAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TOBEATPAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

GREAT (2019)

Grating Reflectors Enabled laser Applications and Training

Read More  

Shape-IT (2019)

Supporting the interaction of Humans and Automated vehicles: Preparing for the EnvIronment of Tomorrow

Read More  

DISTINCT (2019)

Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT)

Read More